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Abstract
Background: In 2017, the Centre for Global Health (CGH) at the University of Oslo in collaboration with the Coalition
for Epidemic Preparedness Innovations (CEPI) and the Norwegian Agency for Development Cooperation (Norad) held a
meeting to discuss together with leading figures in disease control, research and development the issue of neglected
tropical diseases and emerging/re-emerging infectious diseases. This commentary has taken up this discussion and the
conclusions drawn at this meeting to make a case for the opportunity the Sustainable Development Goals (SDGs)
provide in highlighting the interconnectedness of factors that are relevant in the successful fight against neglected
tropical diseases (NTDs) and emerging infectious diseases (EIDS).
Main body: Despite NTDs being endemic and EIDS being epidemic, in order to prevent both disease groups effectively,
it is important to appreciate that they share essential health determining factors, namely: neglect, poverty, a lack of access
to clean water and sanitation facilities and an absence of or severely limited provision of healthcare as well as in many
cases a zoonotic nature. Instead of looking to “simple disease management” for the answer, the SDGs help to understand
the interplay of multiple priority areas and thereby help to promote a more holistic approach to addressing these two
disease groups.
Conclusions: Their commonalities mean that the Global Health community should leverage opportunities and efforts in
the prevention and elimination of both NTDs and EIDs. Doing so using a One Health approach is considered to offer a
“public health best-buy”. Concrete solutions are proposed.
Keywords: Neglected tropical diseases, Emerging infectious diseases, One health, SDGs, Poverty, Neglect
Multilingual abstracts
Please see Additional file 1 for translations of the ab-
stract into the five official working languages of the
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Background
In 2017, the Centre for Global Health (CGH) at the
University of Oslo in collaboration with the Coalition for
Epidemic Preparedness Innovations (CEPI) and the
Norwegian Agency for Development Cooperation (Norad)
held a meeting to discuss together with leading figures in
disease control, research and development the issue of
neglected tropical diseases (NTDs) and emerging /
re-emerging infectious diseases (EIDs). This commentary
intends to share this discussion and the conclusions
drawn at the meeting. Underlying the discussions was a
common understanding that much progress, in particular
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with regards to NTDs has already been made in recent
years. Thus, with the aim to highlight leveraging oppor-
tunities in the prevention and management of NTDs and
EIDs and the need to combine forces in a One Health
manner, the authors will examine each disease area indi-
vidually, before discussing the commonalities and the
additional actions necessary to prevent and alleviate the
associated burden.
Main text
Neglected tropical diseases
Neglected tropical diseases constitute a group of mainly
communicable diseases (with snake bite envenomation
being the first non-communicable disease that has been
added to the list) that primarily affects communities in
resource poor settings in tropical and subtropical condi-
tions. From a focus on individual diseases such as
Chagas disease and leishmaniasis, the term NTDs as a
collective term for a number of diseases that were
biologically dis-similar but affected the same neglected
populations was coined in an attempt to raise awareness
and funding for this group of diseases, considering that
historically very little attention had been paid to them in
comparison to the “big three” diseases, i.e. HIV/AIDS,
malaria and tuberculosis (TB) [1]. Many consider NTDs
to be a “chronic pandemic” due to the large number of
people affected [2]. Arguably, since NTDs mainly concern
people of lower socioeconomic status there is insufficient
attention and financial resources from policy-makers and
research efforts to develop new interventions. NTDs are
highly prevalent both in remote rural areas, as well as in
poor urban settings, mainly - but not exclusively - in low-
and middle-income countries (LMICs) [3]. Importantly,
NTDs are also increasingly prevalent in high income
countries such as the United States of America and some
southern European countries (e.g. Dengue fever, Chagas
disease, leishmaniasis, opisthorchiasis and schistosomiasis)
due to poverty, migration and climate change [4–6]. As
previous LMICs have experienced large economic growth,
the highest overall burden of NTDs is amongst poor
people in large emerging-market economies in the G20
countries, such as India [3].
The World Health Organization’s (WHO) list of NTDs
currently includes 20 diseases [7], while PLoS Neglected
Tropical Diseases (PLoS NTD)– the only journal solely
devoted to the research of NTDs – considers twice as
many diseases to fit in this disease category [8]. A con-
solidated list of NTDs according to the WHO and PLoS
NTD definitions is given in Table 1, indicating the na-
ture of transmission as well as their reservoir. Overall,
they constitute a diverse group of mainly infectious
or communicable diseases with variable opportunities
for elimination as a public health problem or control
and a wide range of reservoirs from solely human to
mainly zoonotic.
According to the Expanded Special Project for Elim-
ination of Neglected Tropical Diseases, 1.5 billion
people are affected by NTDs worldwide and it is esti-
mated that between 350 000 and 500 000 die from
them each year [9–13]. The Global Burden of Disease
Study in 2016 attributed 18.79 million (26.06 million
in 2010) DALYs (disability adjusted life years; calcu-
lated as the sum of the years of life lost due to prema-
ture mortality in the population and the years lost due
to disability for people living with a health condition
and its consequences) to those diseases categorised by
WHO as belonging to the NTDs [14, 15]. In more
in-depth calculations based on the 2010 Global
Burden of Disease study an additional 21.84 million
DALYs were attributed to diseases not listed by WHO
as NTDs amounting to a total of 48 million DALYs
(such in-depth calculations have not been performed
with the 2016 Global Burden of Disease data) [16]. Ac-
cording to the G-Finder survey 2017 that looks at all
the global funding spent on research and development
on what it classifies as neglected not just neglected
tropical diseases (USD 3203 million in 2016), 70% go
to HIV/AIDS (81.55 million DALYs in 2010; 57.57
million, DALYs in 2016; funding of USD 1.10 billion,
2016), malaria (82.68 million DALYs in 2010; 56.20
million DALYs in 2016; funding of USD 576 million,
2016) and tuberculosis (49.40 million DALYs, 2010;
43.56 million DALYs, 2016; funding of USD 568
million, 2016) [17]. According to the G-Finder survey,
the most poorly funded neglected diseases, i.e. leprosy,
cryptococcal meningitis, Buruli ulcer, leptospirosis,
trachoma and rheumatic fever in comparison each
receive less than 0.5% of global funding [17, 18].
A concern in the management of NTDs is the focus
that has been on the use and success of large-scale
preventive chemotherapy (PC) by means of mass drug
administration [19]. Medication that can be used this
way is available for seven NTDs (lymphatic filariasis, on-
chocerciasis, schistosomiasis, soil-transmitted helminths,
trachoma, yaws and scabies [strategies appear promising
and require more research]). In the majority of cases it
is donated by the pharmaceutical companies and repre-
sents the largest donation in history [19, 20]. Medica-
tions are distributed to large populations based on
threshold mapping of at-risk population. Criticism has
been raised at the reliance on a number of single medi-
cation, risking resistance development and a single mode
of prevention for these diseases especially in the light of
the lack of alternative drugs and the underfinanced
developmental pipeline. In response to this, the NTD
NGO Network has developed a framework that recog-
nises the need for a more holistic approach to achieve
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Table 1 Neglected tropical diseases: Overview of WHO and PLOS NTD lists, their main reservoir and mode of transmission
Main reservoir MODE of TRANSMISSION
Human Zoonotic Otherb) Oral/food-borne Vector-borne Otherc)
Viral diseases
Dengue and Chikungunya feversa X X
Japanese encephalitis X X
Jungle yellow fever X X
Other arboviral infections X X
Rabiesa X Xe
Rift Valley fever X X
Viral haemorrhagic fevers X X X Xd, e
Bacterial diseases
Bartonellosis X X X Xe
Bovine tuberculosis in humans X X
Buruli ulcera Xh Xh Xd
Cholera X X
Diarrhoeal diseases (Shigella, Salmonella, E. coli) X X
Leprosya X (X) Xe
Leptospirosis X X
Trachomaa X Xe
Treponematoses (Yaws, Endemic syphilis, Pinta)a X Xe
Helminthic diseases
Dracunculiasisa X X
Echinococcosisa X X
Food-borne trematodiasesa X X
Loiasis X X
Lymphatic filariasis (LF)a X X
Onchocerciasisa X X
Schistosomiasisa X X Xe
Soil-transmitted helminthiases (Ascariasis,
Hookworm disease, Trichuriasis, Strongyloidiasis)a
X X Xe
Taenia solium (Neuro)Cysticercosis/Taeniosisa X (only taeniosis) X
Toxocariasis and other larva Migrans diseases X X Xe
Protozoan diseases
Amoebiasis X X
Balantidiasis X X
Chagas diseasea X X Xg
Giardiasis X X
Human African trypanosomiasis (HAT)a X X X
Leishmaniasisa X X X Xg
Ectoparasitic diseases
Myiasis X X
Scabiesa X X
Snake bite envenoming X Xe
Note: a) indicates the 20 diseases categorised by WHO as belonging to the neglected tropical diseases; ectoparasitic and fungal infections as well as snakebite
envenoming have recently been added in 2017 on the occasion of the 10th meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases
b) Environment
c) unknownd, direct contacte, fetomaternalg
h) possible zoonotic and/or environmental reservoir
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sustainable progress, building on the five-pillar disease
strategy outlined by WHO (PC, disease management,
vector control, veterinary public health and water, sani-
tation and hygiene) [21]. This framework advocates for a
more systematic approach to the inclusion of a broader
range of interventions in NTD programme planning,
considering environmental factors such as vector con-
trol, management of the animal reservoir in zoonotic
diseases and engagement of the water, sanitation and
hygiene sector as well as behaviour change and the need
for social inclusion [22].
Emerging and re-emerging infectious diseases
The grouping of diseases into emerging and re-emerging
infectious diseases (EIDs) has been around for much
longer compared to NTDs. WHO defines EIDs as those
diseases “whose incidence in humans has increased dur-
ing the last two decades or which threaten to increase in
the near future. The term includes newly-appearing in-
fectious diseases or those spreading to new geographical
areas. It also refers to those that were easily controlled
by chemotherapy and antibiotics but have developed
antimicrobial resistance” [23].
Owing to recent attention to EIDs, development part-
ners, WHO and public health agencies link the particu-
lar threat of how EIDs represent a health and security
risk by crossing national borders as well as through
climate change and urbanisation [13]. With our world
becoming ever more interconnected and globalised, in
particular via air travel as well as trade and migration
routes, the risk of fast and uncontrolled spread of
diseases across national and international borders, as
well as continents, is increasing at a fast rate. Public
health measures and health care systems that are break-
ing down as a result of conflict or economic collapse are
also concerning risk factors for EIDs [24].
While much attention has been paid to viral infections,
research suggests that 54% of EIDs are actually caused by
bacteria, a large number of which reflect drug-resistant
microbes [25]. The fact that WHO had to respond to 50
EID emergencies in 48 countries within six months
around the end of 2017 and the beginning of 2018, nine of
which were grade 3 emergencies, the highest level in
WHO grading system, demonstrates how EIDs set the
public health agenda [26]. These emergencies included
cases of Middle East respiratory syndrome coronavirus
(MERS-CoV) in Oman, Saudi Arabia, as well as the UK,
the Plague in Madagascar, outbreaks of cholera in Kenya,
Nigeria and Zambia and not to forget the second major
outbreak and ongoing Ebola crisis in the Democratic
Republic of the Congo, to name but a few [27, 28]. These
outbreaks concern diseases that are on the WHO list of
Blueprint priority diseases, meaning they pose a public
health risk because of their significant epidemic potential
and too little resources dedicated to countermeasures in
the form of research and development (see also Table 2
for the complete WHO list of Blueprint diseases).
The significant burden EIDs can have on economies
and public health including healthcare systems has be-
come very apparent in the aftermath of the 2014 Ebola
outbreak. The World Bank estimated the overall impact,
covering the crisis in 2014 to 2015 as well as projections
into 2016 on Guinea, Liberia and Sierra Leone at USD
2.8 billion in total. The healthcare systems were signifi-
cantly affected by the Ebola outbreak, leading to a loss
in healthcare workforce and reduced access to health-
care services, responsible for an additional 106 000
deaths in Guinea, Liberia and Sierra Leone, according to
the Center for Disease Control and Prevention. These
include 1091 additional deaths due to HIV/AIDS, 2714
additional deaths due to TB and 6818 additional deaths
due to malaria [29].
Similar to NTDs, animals constitute an important res-
ervoir of many pathogens causing EIDs. It is estimated
that 60% of all human infectious diseases are of zoonotic
origin and approximately 75% of all pathogens that lead
to EIDs in humans are transmitted from the animal
kingdom and in fact cause three out of five new diseases
every year [30]. These percentages have been increasing
over the last decades [25, 31, 32]. Rising population and
subsequent increasing demand for land and food has led
to farming land as well as village and city borders
moving closer to wildlife’s natural habitat, increasing the
chances for human-wildlife contact. Furthermore, animal
transportation as part of global food chains not only
propagates the spread of diseases amongst animals but
also the risk for the spread to humans [26].
While the continued neglect of the chronic NTD pan-
demic primarily affect populations in resource poor
settings, new epidemics of EIDs have gained attention due
Table 2 WHO’s Blueprint priority diseases
Zoonosis Vector Other
Crimean-Congo haemorrhagic fever (CCHF) X X
Ebola virus disease and Marburg virus disease X
Disease Xa X X X
Lassa fever X
Middle East respiratory syndrome coronavirus
(MERS-CoV) and severe acute respiratory
syndrome (SARS)
X
Nipah henipaviral diseases X
Rift Valley fever X X
Zika virus X X
Note: a “Disease X represents the knowledge that a serious international
epidemic could be caused by a pathogen currently unknown to cause human
disease, and so the R&D Blueprint explicitly seeks to enable cross-cutting R&D
preparedness that is also relevant for an unknown “Disease X” as far as
possible” (http://www.who.int/blueprint/priority-diseases/en/)
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to their potential spread and risk to everyone, including
those in high-income countries. EIDs have thus been
recognized as posing a substantial threat to global health
security. This has been particularly driven by the recent
2014 Ebola outbreak as well as the rising concerns regard-
ing antimicrobial resistance. As a result, initiatives such
as the Coalition for Epidemic Preparedness Innovation
(CEPI), have emerged. CEPI is a coalition whose role is
to finance and coordinate the development of new
vaccines in order to prevent and or contain future in-
fectious disease epidemics [33]. With initial funding of
about USD 630 million CEPI has focused on developing
vaccine candidates ready for large scale efficacy trials
against three of WHO’s Blueprint priority diseases,
namely Lassa fever, Middle East Respiratory Syndrome
(MERS) and Nipah disease, all of which have large
animal reservoirs (Table 2). In addition, CEPI focuses
on helping finish the development of approved vaccines
against Ebola [34]. Moreover, the coalition supports
the development of well-characterized vaccine plat-
forms to accelerate development of vaccines against
unknown pathogens [35]. CEPI will also support in-
novations and effective processes for licensing and
using vaccines, outcomes that may have impact be-
yond the specific diseases.
CEPI is an important initiative and Global Health player.
The global health crisis of the 2014 Ebola outbreak has
however illustrated that multiple reforms are essential in
order to be adequately prepared for the next pandemic
[36]. Moreover, many other EIDs still do not benefit from
the needed attention and are still neglected in terms of
funding, research and innovative measures for prevention,
as well as healthcare system investments to meet the
Sustainable Development Goals (SDGs) [37–39].
NTDs, EIDs and the SDGs
As opposed to EIDs, many NTDs are of endemic nature
but clearly an overlap exists such as in the case of leish-
maniasis, which can cause outbreaks (see wars in Syria
and Iraq) or Helicobacter pylori, which is classified as
an EID but is endemic in nature (44% of the world is
colonized) [40]. Nevertheless, for the prevention of
both disease groups, it is important to appreciate that it
is the most underserved and most socio-economically
disadvantaged population groups that are most affected
and at risk. In addition, these community often live in
areas where environmental and ecological factors also
interact to promote the spread of diseases [25, 41, 42],
for example by living in close proximity to animals –
domestic and wild - and experience a lack of access to
clean water and sanitation facilities [4]. Absence of or
severe deficits in healthcare systems or the inability to
access these healthcare services also compound the im-
pact of these diseases.
It hence becomes very apparent that effectively dealing
with these disease groups is not a matter of “simple
disease management”, but that integrated and interdis-
ciplinary approaches are required to improve health
sustainably. The 2030 Sustainable Development Goals
Agenda offers a great opportunity as it helps to highlight
priority areas for action and promotes a more holistic
approach [43]. Figure 1 below highlights those SDGs
central to addressing both NTDs and EIDs effectively.
Particularly relevant to NTDs and EIDs is the connec-
tion between the health of the environment, the health
of the people, as well as the health of animals. The latter
is not explicitly stated or referred to in the SDGs but is
of equal importance. We refer to this as One Health.
One Health is understood as “an approach to designing
and implementing programmes, policies, legislation and
research in which multiple sectors communicate and
work together to achieve better public health outcomes”
[44]. We therefore urge the global community to
continue to advocate for integrated cross-sectorial
approaches in the prevention and management of dis-
eases that predominantly affect the poor and neglected
people and that activities addressing NTDs and EIDs
take an approach that considers human, animal and en-
vironmental health conjointly. This also incorporates the
control of vectors involved in the transmission of dis-
eases (see Table 1) as well as the prevention of their
spread to and risk for humans.
One health and global politics
At the second annual review of WHO Blueprint diseases
in 2018 (Table 2), the impact of environmental issues on
the Blueprint diseases was set on the agenda for upcoming
reviews [34]. This demonstrates two important aspects:
Firstly, as we have stated above, EIDs, similarly to NTDs,
require a One Health approach, which includes environ-
mental issues if diseases are to be meaningfully and
sustainably prevented and managed. Secondly, a One
Health, interdisciplinary approach is not yet sufficiently
driving activities to prevent such diseases from emerging.
In a speech in February 2018 in Thailand on the threat
of EIDs WHO’s Director General, Dr. Tedros Adhanom
Ghebreyesus said, “We are setting ourselves a goal that
over the next five years, 1 billion more people will be
better protected from epidemics and other health emer-
gencies” [26]. The corresponding WHO’s Thirteenth
General Programme of Work, 2019–2023, emphasises
four points WHO also seeks to ensure: 1) access to
essential life-saving health services and public health
interventions, 2) appropriate equipment of countries
to mitigate risks from high-threat infectious hazards,
3) that any gaps are identified in health emergency
preparedness (under the International Health Regula-
tions) by countries themselves, and 4) that national
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health-emergency programmes receive support by
WHO Health Emergencies Programme [45].
These four points are reiterated by Kluge and colleagues
in their article on Global Health security and the
International Health Regulations requirements, in which
they go even further making a very valid case for the
necessity of joining up “thinking between health system
strengthening activities and health security efforts for
prevention, alert and response” [46]. The authors also
acknowledge the crucial role of the veterinary public
health and agricultural sectors in responding to the poten-
tial threats associated with the rearing and moving of
animals and livestock. However, we argue that more
urgent action and financial commitments are needed to
promote closer collaboration and equal contribution from
the animal and environmental sectors. Health systems
alone cannot address socio-economic determinants of
health such as water, sanitation, and hygiene, proximity of
living with animals, animal health overall and the need of
surveillance of livestock and where possible wildlife as well
as vectors. Further, poverty is a crosscutting issue. The
tendency of people living in resource-poor settings to fall
ill and endure the harmful economic effects of seeking
healthcare, as well as underfunded health systems demon-
strate how poverty is a chronic threat for current and
future epidemics and pandemics. Investment in the health
of the poor, poverty diseases and universal health coverage
is a necessity to reach the SDGs on health.
That this is possible and effective was shown by Joyce
Moriku Kaducu, the Minister of State for Primary
Health Care in Uganda who spoke at the meeting in
Oslo about the progress and challenges with regards to
the NTDs and was able to highlight key factors that have
contributed to the Ugandan success, such as the elimin-
ation of the Guinea worm (Uganda was certified free of
Guinea worm in 2009) and the reduction in the burden
of disease for many NTDs. Progress has also been made,
for example, with regards to trachoma, with a reduction
of people at risk from an estimated 10 million in 2014 to
300 000 in 2018 [47]. Amongst those key factors were 1)
collaborating with other ministries such as agriculture,
animal industries and fisheries and education, 2) inter-
ventions that were pro-poor and targeted communities
living in slums and poor rural and urban areas as well
as, 3) women and children were empowered both with
knowledge and economically about NTDs associated
with poor sanitation since they are typically the most
affected population group. Thus, paying attention to the
underserved and working in partnership with other
disciplines and ministries as well as empowering women
is effective and it points to the importance of having the
attention of the politicians [48]. Despite the successes, it
Fig. 1 The SDGs central to addressing NTDs and EIDs in a multidisciplinary way ©Center for Global Health, Technical University of Munich
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is important to note that cross-border transmission be-
tween the Democratic Republic of the Congo and South
Sudan remains a challenge for elimination of NTDs as a
public health problem in endemic districts in Uganda.
“A public health best buy”
The meeting in Oslo highlighted the need and interest of
the Global Health community to leverage opportunities in
the prevention and elimination of both NTDs and EIDs.
Delivering on NTDs and EIDs through both cross-sectoral
and targeted initiatives will be beneficial to both human
and animal health and thus contribute positively to overall
health and economic security. Schar and colleagues even
speak of an estimated global benefit of over USD 30 billion
annually as a result of “a yearly investment of USD 1.9–3.4
billion to strengthen animal and human health systems”
[32]. According to the World Bank Report that forms the
basis of these estimated, investments need to be directed
amongst others to staffing and capacity of veterinary
professionals, surveillance and control mechanisms and
general management and regulations in low and middle
income countries [49]. In an important next step, veterin-
ary and human health systems need to communicate and
share data in order to identify potential areas of risk and
gaps in control mechanisms. The extent of the benefit can
be explained by the fact that severe economic damages
associated with pandemics, such as seen in the 2014 Ebola
crisis, as well as estimated for NTD infections, would be
avoided. The public health best buy thus means that rela-
tively small investments that are wisely allocated in order
to leverage on existing systems, improve surveillance,
prevent chronic morbidities of disease and link human,
animal and environmental health can help to achieve
large-scale (and if maintained long-term) health and
economic improvements as well as health security [50].
Despite the promising economic case that can be made,
panellists in Oslo wondered whether the global landscape
with its current activities favour drug developments and
donations rather than effectively using treatment and
prevention strategies that already exist and scaling them
up to everyone in need. Combating NTDs and EIDs in
many cases can be effective at primary healthcare and
district healthcare facilities. Dr. Mwelecele Malecela, Dir-
ector WHO Department of Control of Neglected Tropical
Diseases, has just made such a case at the global confer-
ence on mycetoma in Sudan, February 2019, stating that,
“An essential first step could be to look at how we can
integrate mycetoma interventions within primary health
care delivery” [51]. Therefore, we think it necessary for
coordinated funding and capacity building to also be di-
rected towards strengthened primary health care services
for sustainable impact to be achieved. This would imply
active involvement of politicians and governments and
investment in universal health coverage [39]. Yet, as was
argued by the panellists in Oslo, while neglect is a political
issue (neglect of the underserved people that are particu-
larly affected by both NTDs and EIDs), technical discus-
sions or philanthropic efforts, though absolutely necessary
and valuable, may divert our attention from the role of
politicians, governments and responsible decision-makers
[42]. Unless this neglect is addressed, the discussants
worried that the current scenario of resource constraints
faced by people and animals will be maintained [25, 52].
Oslo proceedings
It was concluded in Oslo that the burden of NTDs and
EIDs disproportionally affect the most neglected and
underserved populations, in LMICs. They are diseases of
poverty, neglected people, neglected research and develop-
ment, knowledge, data and access to diagnostic, treatment
and prevention mechanisms. Furthermore, this neglect
takes place at the local, national and global level. Strength-
ening health systems, community ownership of disease sur-
veillance and programmes as well as different and/or novel
approaches to dealing with and preventing NTDs and EIDs
simultaneously i.e. addressing living conditions, behaviour
change and disease education, are required to combat the
current and future challenges. Reciprocally, integrating
programmes into health systems that effectively com-
bat NTDs and prevent the spread of EIDs has the po-
tential to accelerate progress towards Universal
Health Coverage while advancing the broader SDGs
for 2030. Finally, it was considered imperative to also
address the zoonotic roots of NTDs and EIDs, the
majority of which are not prioritised and targeted by
pharmaceutical companies and governments. Address-
ing zoonotic diseases by taking a One Health ap-
proach is a great opportunity to tackle NTDs and
EIDs in a holistic and multidisciplinary way [42, 53].
This has now also been taken up by a Lancet One
Health Commission of which some of the authors of
the current paper are part and that will hold its first
meeting again in Oslo at the beginning of May 2019.
The key challenges and solutions that were highlighted
can be found in the summary box below.
Summary Box: Key challenges and solutions for combat-
ting NTDs and EIDs discussed at the Oslo conference
 Lack of incentives for R&D of vaccines and treatments
for both NTDs and EIDs.
 Reaching neglected populations.
 Building resilient health systems.
 Timely access to already-existing treatments in rural
and urban clinics in the Global South.
 Including engaged communities, civil society,
political stakeholders.
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 Amplifying human and financial resources from both
local and international sources.
 Strengthening disease surveillance and reporting.
 Implementing infection control measures.
 Prioritizing a disease for NTD lists.
 Joining forces in global health research and
building common frameworks based on a
common set of principles.
 Calling for One Health research activities and
strategies.
 Research to anticipate future climate patterns and
natural disasters, which affect agriculture and
livelihoods of people in NTD and EID affected regions
and thus pre-empting the spread of NTDs and EIDs.
 Addressing the SDGs, which run through the heart
of the problem of poverty, sanitation, education,
hunger, health of the planet, health of cities and
health of the people.
Conclusions
In our view, a multidisciplinary One Health approach,
which requires collaboration across sectors and minis-
tries, is indispensable for successful prevention, control
and elimination of most NTDs and EIDs and should
thus be given highest priority. This will yield gains for
patients affected by NTDs and EIDS, but also other
causes of premature illness and deaths. The following
solutions were proposed at the meeting in Oslo and are
emphasised again in this commentary: 1) pushing more
forcefully for a One Health approach that includes advo-
cacy for and investment in animal health research and
community livelihood that then become core compo-
nents of national programmes, 2) encouraging and
supporting countries to develop national action plans
(NAPs) that address both, the prevention of NTDs and
EIDs by considering to leverage opportunities in terms
of for example the strengthening of human and animal
health systems and their coordination, 3) fostering
research to anticipate future climate patterns, natural di-
sasters, which affect agriculture and livelihoods of people
in affected regions and thus pre-empting the spread of
neglected- and emergence of new- diseases, 4) strengthen-
ing disease surveillance and reporting, 5) continued devel-
opment of medical countermeasures against NTDs and
EIDs, and finally 6) addressing the SDGs, which run
through the heart of the problem of poverty, sanitation,
education, hunger, and health of the people. All these re-
quire neglected populations to be reached. Joining forces
in global health research and policy are considered one of
the most essential building blocks for all of the above. This
discussion will be taken further in the upcoming One
Health Lancet Commission, co-chaired by this article’s
co-authors Dr. John Amuasi and Prof Andrea Winkler.
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